Page last updated: 2024-09-03

ah 6809 and Carcinoma, Non-Small Cell Lung

ah 6809 has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Jin, H; Lei, Y; Luo, H; Su, C; Wang, T; Zhong, B; Zhuang, M; Zou, J1
Casibang, M; Moody, TW1

Other Studies

2 other study(ies) available for ah 6809 and Carcinoma, Non-Small Cell Lung

ArticleYear
Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer.
    Journal of experimental & clinical cancer research : CR, 2011, Jan-10, Volume: 30

    Topics: Adult; Aged; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 2; Enzyme Activators; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prostaglandins E; Protein Kinase C; Pyrroles; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Up-Regulation; Vascular Endothelial Growth Factor A; Xanthones

2011
AH6809 antagonizes non-small cell lung cancer prostaglandin receptors.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 36, Issue:1

    Topics: Binding Sites; Calcium; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Membrane; Colony-Forming Units Assay; Cyclic AMP; Cytoplasm; Dinoprostone; DNA Primers; Humans; Lung Neoplasms; Prostaglandin Antagonists; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xanthenes; Xanthones

2002